Notably, CDR C0 group was infiltrated with co-inhibitors and had higher expression of HAVCR2 than C2, C3, C4, providing sites for ICIs to combine and increasing anti-cancer CD8+ T cells immunity. This evidence concerns the gene HAVCR2 and cancer.